Stock NOVA NOVA MENTIS LIFE SCIENCE CORP.
Add to a list
To use this feature you must be a member
Log inSign up

News Nova Mentis Life Science Corp.

Equities

NOVA

CA66980V1067

Market Closed - Canadian Securities Exchange
Other stock markets
 03:55:56 2024-04-16 pm EDT 		5-day change 1st Jan Change
0.01 CAD 0.00% Intraday chart for Nova Mentis Life Science Corp. -33.33% -50.00%
Apr. 08 Nova Mentis Life Science Corp. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Feb. 26 Nova Mentis Life Science Corp. Announces the Appointment of Steve Loutskou to the Board of Directors CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Nova Mentis Life Science Corp. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Nova Mentis Life Science Corp. Announces the Appointment of Steve Loutskou to the Board of Directors
CI
Nova Mentis Announces Change of Directors
NE
Nova Mentis Life Science Corp. Announces Management Changes
CI
Nova Mentis Life Science Corp. Announces Resignation of Dr. Stephen Glazer as Chief Scientific Officer and Director
CI
Nova Mentis Life Science Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
CI
Nova Mentis Applauds Government Decision to Create Rare Disease Advisory Group
NE
Nova Mentis Life Science Corp. - Participant Screening Underway in Canada's First Psilocybin Clinical Trial for Fragile X Syndrome
AQ
Nova Mentis Life Science Corp. Announces Participant Screening Underway in Canada's First Psilocybin Clinical Trial for Fragile X Syndrome
CI
Nova Mentis Life Science Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
CI
Nova Mentis Life Science Corp. Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
Nova Mentis Life Science Corp. Reports Earnings Results for the Full Year Ended December 31, 2022
CI
Nova Mentis Life Science Corp. Auditor Raises 'Going Concern' Doubt
CI
Nova Mentis Begins Recruitment in First-of-its-Kind Health Canada Psilocybin Trial
AQ
KGK Science Inc. Begins Recruitment in First-of-its-Kind Health Canada Approved Psilocybin Trial
CI
KGK Sciences Inc. Begins Recruiting Participants, on Behalf of Client Nova Mentis Life Science Corp. in First-Ever Clinical Trial Investigating Effects of Psilocybin on Adults Diagnosed with Fragile X Syndrome
CI
Nova Mentis Receives Institutional Review Board Approval to Commence Psilocybin Clinical Trial
AQ
Nova Mentis Life Science Corp. Receives Institutional Review Board Approval to Commence Psilocybin Clinical Trial
CI
Nova Mentis Provides Corporate Update and 2023 Outlook
AQ
Novel Therapeutic Solutions are needed as Autism Rates Increase
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. NOVA Stock
  4. News Nova Mentis Life Science Corp.